Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FQVKA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,883
Award facts
- Contract value 100% obligated
- $10,883.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,883.17 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems, including military and veteran care programs. As a leading vendor within the DLA's Medical Supply Chain, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. This delivery order for Jardiance, a diabetes management medication, exemplifies the company's role in supplying essential prescription pharmaceuticals to support Department of Defense healthcare requirements. The underlying SPE2DX contract enables flexible acquisition of pharmaceutical commodities to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Quick answers
Who was awarded contract SPE2DB25FQVKA?
SPE2DB25FQVKA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQVKA worth?
The government has obligated $10,883 on SPE2DB25FQVKA.
Is contract SPE2DB25FQVKA an order under another contract?
Yes. SPE2DB25FQVKA is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQVKA competed?
The extent of competition for SPE2DB25FQVKA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award